TY  - JOUR
AB  - Respiratory viruses are known to be the most frequent causative mediators of lung infections in humans, bearing significant impact on the host cell signaling machinery due to their host-dependency for efficient replication. Certain cellular functions are actively induced by respiratory viruses for their own benefit. This includes metabolic pathways such as glycolysis, fatty acid synthesis (FAS) and the tricarboxylic acid (TCA) cycle, among others, which are modified during viral infections. Here, we summarize the current knowledge of metabolic pathway modifications mediated by the acute respiratory viruses respiratory syncytial virus (RSV), rhinovirus (RV), influenza virus (IV), parainfluenza virus (PIV), coronavirus (CoV) and adenovirus (AdV), and highlight potential targets and compounds for therapeutic approaches.
AU  - Kleinehr, Jens
AU  - Wilden, Janine J.
AU  - Börgeling, Yvonne
AU  - Ludwig, Stephan
AU  - Hrincius, Eike-Roman
DA  - 2021-10-14
DO  - 10.3390/v13102068
KW  - respiratory viruses
KW  - metabolism
KW  - host targeted antivirals
LA  - eng
N1  - Viruses 13 (2021) 10, 2068, 1-20
N1  - Finanziert durch den Open-Access-Publikationsfonds der Westfälischen Wilhelms-Universität Münster (WWU Münster).
N1  - This work was supported by the German Research Foundation (DFG) (grants SFB1009 B02 and B13, CRU342 P6, Lu477-23).
PY  - 2021-10-14
TI  - Metabolic Modifications by Common Respiratory Viruses and Their Potential as New Antiviral Targets
UR  - https://nbn-resolving.org/urn:nbn:de:hbz:6-26009420690
Y2  - 2024-11-21T22:30:02
ER  -